Janux Therapeutics Partners with Bristol Myers Squibb in Major Cancer Drug Deal
Janux Therapeutics announces collaboration with Bristol Myers Squibb to develop novel tumor-activated cancer therapy, with potential payments up to $850 million.
NOTRELOAD AI
GE Aerospace Q4 Beats Expectations But Growth Slows
GE Aerospace's Q4 2025 results exceeded Wall Street forecasts with strong commercial engine performance, though revenue growth is decelerating. Stock initially surged then fell 3%.
PayPal Acquires Cymbio to Dominate AI-Powered Shopping
PayPal buys Israeli startup Cymbio to help merchants sell through AI chatbots like ChatGPT and Copilot. Deal valued in hundreds of millions, closing in 2026.
Mobileye Stock Drops Despite Robotics Deal as 2026 Guidance Disappoints
Mobileye shares fall as 2026 revenue and profit guidance miss Wall Street expectations, despite $900M Mentee Robotics acquisition expanding into humanoid robots and Physical AI.
McCormick Faces Margin Pressure Despite Sales Growth in 2026 Outlook
McCormick forecasts lower-than-expected 2026 profits as tariffs, commodity costs, and changing consumer habits squeeze margins despite strong sales projections.
Greenwich LifeSciences Stock Surges on FDA Approval for Breast Cancer Trial
Greenwich LifeSciences (GLSI) shares jump 42% after FDA approves commercial GP2 for Phase III breast cancer prevention trial, reducing regulatory risks ahead of license application.